Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Two more applications joined mHealthBelgium – Healthentia and Sunrise

05 Aug 2020

In July 2020, two new apps entered the level 1 of the mHealthBelgium validation pyramid.

The Healthentia key features:

  • Can be used by
    • patients – subjects to a clinical study
    • investigators of clinical studies
    • healthy individuals
  • The primary function is to support the capturing of data in clinical studies
  • Individuals can report and monitor their outcomes (e.g., symptoms) and activity and receive automatic-generated questionnaires for wellbeing. Aggregated data provided after users’ consent, can be processed for conducting non-profit research studies
  • In sponsored clinical trials the app can be used to carry out study protocols
  • The mobile application can be paired with wearable devices (e.g., activity trackers), as well as other medical devices and sensors.
  • It is planned to add eHealth services to the users in next versions of Healthentia
  • The application is free-of-charge for individuals, while for sponsor organizations, there is a fee per user per month in PaaS or SaaS model.

The Sunrise key features:

  • Sunrise is a medical device (Class IIa) that includes a mobile application, a sensor to be placed on the chin and a web platform for healthcare professionals
  • The sensor placed on the chin records the mandibular movements
  • The app analyzes the data gathered by the sensor from a secured cloud in real-time using artificial intelligence
  • Clinical tests carried out on 400 patients show a 90% agreement with polysomnography for the diagnosis of obstructive sleep apnea
  • It is approved for both adults and children
  • Pricing information can be obtained by request on the manufacturer’s website

See the full details on Healthentia here, and on Sunrise here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.